Nat. Rev. Urol. doi: /nrurol

Slides:

Advertisements

Similar presentations

In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.

Advertisements

Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.

Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma

Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,

Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.

A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.

بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.

Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.

Figure 4 PET imaging in experimental pancreatic cancer

Volume 64, Issue 5, Pages (November 2013)

Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer

Klinikum rechts der Isar, Technische Universität München

Bladder Cancer and Prostatic Cancer

74-year-old man with stage T2a Gleason score prostate cancer (prostate specific antigen = ng/mL) in right transition zone (TZ) with history.

Prostate cancer นพ.ชัชชัย หอมเกตุ.

Post Op Positive Apex Margins Case 3: Prostate_3

New Tracers for Prostate Cancer Imaging

Volume 70, Issue 5, Pages (November 2016)

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Post Op Positive Seminal Vesicle Case 4: Prostate_4

Nat. Rev. Urol. doi: /nrurol

Figure 2 Recruitment of experts to the Delphi study

Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma – Is PSMA-PET-CT a helpful tool in radiation oncology? Laila König, Henrik.

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Jaden D. Evans, MD, Krishan R

Volume 73, Issue 5, Pages (May 2018)

Figure 3 Semantic model of the active surveillance (AS) timeline

Nat. Rev. Urol. doi: /nrurol

The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.

Figure 2 Representative images from a right radical

Volume 64, Issue 5, Pages (November 2013)

Nat. Rev. Urol. doi: /nrurol

Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI- RADS v2) scoring system in diagnosis of peripheral zone prostate cancer

99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer Tobias Maurer, Stephanie Robu, Margret Schottelius,

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Luis Martínez-Piñeiro European Urology Supplements

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

External Beam Radiotherapy as Curative Treatment of Prostate Cancer

Figure 3 Algorithm for the determination of the clinical

Nat. Rev. Urol. doi: /nrurol

Figure 6 Image sequence demonstrating coronal cuts on MRI

Nat. Rev. Urol. doi: /nrurol

Figure 4 New PET radiotracers in lymphoma

Nat. Rev. Urol. doi: /nrurol

Uptake of Prostate-Specific Membrane Antigen (PSMA) in adenoid cystic carcinoma – Is PSMA-PET-CT a helpful tool in radiation oncology? Laila König, Henrik.

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

the SNP profile using 26 prostate cancer GWAS risk SNPs

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Prostate Cancer Update

European Urology Oncology

False-positive findings at the base of the left pterygoid process on conventional CT images alone in a 63-year-old woman with nasopharyngeal carcinoma.

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Nat. Rev. Urol. doi: /nrurol

Fernando P. Secin, Fernando J. Bianco, Nicholas T

Figure 3 Target volume definitions

Prostate-specific membrane antigen positron emission tomography/computed tomography as a potential tool to assess and guide salivary gland irradiation

Volume 4, Issue 1, Pages (February 2006)

Figure 4 Algorithm for when to determine PTEN

History: 71 yo male post radical prostatectomy 4 years ago for Gleason 4+5 prostate cancer Pre-op staging CT and MDP bone scan were negative for metastatic.

Study overview. Study overview. A, Schematic illustrating clinical trial design and the nature and number of tissue specimens available for downstream.

PSMA expression in pre- and posttreatment prostate carcinoma serum.

Patient 10. Patient 10. A 67-year-old man after radiation therapy at an outside hospital for base-of-tongue cancer. A and B, Axial contrast-enhanced CT.

False-positive findings at the base of the left pterygoid process on conventional CT images alone in a 63-year-old woman with nasopharyngeal carcinoma.

Presentation transcript:

Nat. Rev. Urol. doi:10.1038/nrurol.2016.26 Figure 6 68Ga-PSMA–PET–CT of a 74-year-old patient with recurrent prostate cancer (initial Gleason score 7) after radical prostatectomy and local salvage radiotherapy with rising serum PSA value (1.76 ng/ml at the time of assessment) Figure 6 | 68Ga-PSMA–PET–CT of a 74-year-old patient with recurrent prostate cancer (initial Gleason score 7) after radical prostatectomy and local salvage radiotherapy with rising serum PSA value (1.76 ng/ml at the time of assessment). a | Contrast-enhanced CT shows a mass in the area of the former left seminal vesicle having residual tissue, reactive fibrosis or recurrent disease. b | PET and c | fused PET–CT images demonstrate intense 68Ga-PSMA uptake, indicative of a locally recurrent tumour. Salvage PSMA-radioguided surgery revealed soft-tissue poorly differentiated adenocarcinoma of the prostate (Gleason score 7) including a seminal vesicle with a cribriform carcinoma. PSMA, prostate-specific membrane antigen. Maurer, T. et al. (2016) Current use of PSMA–PET in prostate cancer management Nat. Rev. Urol. doi:10.1038/nrurol.2016.26